This probe leverages Angiopep-2-mediated targeting of LRP1 receptors to facilitate efficient BBB crossing, followed by a cascaded activation process triggered specifically by the tumor-associated enzymes cathepsin B (Cat B) and monoamine oxidase (MAO). The gene discussed is CTSB; the disease is neoplasm.